Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 30 | 2024 | 5319 | 1.990 |
Why?
|
DNA, Neoplasm | 10 | 2020 | 1743 | 1.890 |
Why?
|
Lung Neoplasms | 43 | 2024 | 13383 | 1.750 |
Why?
|
Drug Resistance, Neoplasm | 28 | 2024 | 5304 | 1.380 |
Why?
|
Acrylamides | 7 | 2021 | 259 | 1.020 |
Why?
|
Polymerase Chain Reaction | 8 | 2024 | 6074 | 0.890 |
Why?
|
Protein Kinase Inhibitors | 24 | 2023 | 5672 | 0.880 |
Why?
|
Neoplastic Cells, Circulating | 3 | 2018 | 943 | 0.840 |
Why?
|
Aniline Compounds | 6 | 2021 | 1068 | 0.780 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 11 | 2023 | 1745 | 0.690 |
Why?
|
High-Throughput Nucleotide Sequencing | 12 | 2024 | 3634 | 0.680 |
Why?
|
Mutation | 38 | 2024 | 30015 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-met | 7 | 2022 | 571 | 0.570 |
Why?
|
Saliva | 1 | 2019 | 828 | 0.470 |
Why?
|
Neoplasms | 18 | 2024 | 22131 | 0.460 |
Why?
|
Antineoplastic Agents | 20 | 2023 | 13635 | 0.440 |
Why?
|
Cell Line, Tumor | 31 | 2024 | 16968 | 0.440 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2019 | 491 | 0.440 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.430 |
Why?
|
Mass Spectrometry | 7 | 2015 | 2189 | 0.430 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.420 |
Why?
|
Exodeoxyribonucleases | 2 | 2024 | 191 | 0.420 |
Why?
|
Spheroids, Cellular | 5 | 2023 | 329 | 0.410 |
Why?
|
DNA, Viral | 1 | 2019 | 2194 | 0.400 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1608 | 0.370 |
Why?
|
Phosphotransferases | 1 | 2011 | 303 | 0.360 |
Why?
|
Gene Amplification | 4 | 2024 | 1087 | 0.350 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2010 | 72 | 0.340 |
Why?
|
Genes, ras | 3 | 2022 | 654 | 0.340 |
Why?
|
Signal Transduction | 15 | 2024 | 23415 | 0.320 |
Why?
|
Quinazolines | 2 | 2015 | 1371 | 0.310 |
Why?
|
Genotype | 11 | 2021 | 12977 | 0.310 |
Why?
|
Phosphoproteins | 4 | 2024 | 2445 | 0.310 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2006 | 506 | 0.310 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2024 | 423 | 0.300 |
Why?
|
DNA Mutational Analysis | 5 | 2024 | 4110 | 0.300 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1612 | 0.280 |
Why?
|
Neoplasm Proteins | 6 | 2021 | 3607 | 0.270 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1780 | 0.270 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2020 | 350 | 0.260 |
Why?
|
Killer Cells, Natural | 3 | 2024 | 2191 | 0.260 |
Why?
|
Proteomics | 5 | 2015 | 3836 | 0.250 |
Why?
|
Melanoma | 3 | 2020 | 5696 | 0.250 |
Why?
|
Protein Array Analysis | 4 | 2006 | 399 | 0.250 |
Why?
|
Exons | 3 | 2024 | 2381 | 0.250 |
Why?
|
Humans | 107 | 2024 | 760740 | 0.250 |
Why?
|
Oncogenes | 2 | 2021 | 1220 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2020 | 561 | 0.240 |
Why?
|
Proteome | 10 | 2013 | 1857 | 0.240 |
Why?
|
Neoplasms, Experimental | 2 | 2021 | 1226 | 0.240 |
Why?
|
Adenocarcinoma | 5 | 2024 | 6345 | 0.240 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2894 | 0.230 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2022 | 11735 | 0.230 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5811 | 0.230 |
Why?
|
Carbonic Anhydrases | 1 | 2024 | 108 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3599 | 0.220 |
Why?
|
Immunotherapy | 5 | 2024 | 4642 | 0.220 |
Why?
|
Receptor, erbB-2 | 3 | 2024 | 2553 | 0.220 |
Why?
|
DNA Copy Number Variations | 5 | 2024 | 2020 | 0.210 |
Why?
|
Mice | 31 | 2024 | 81368 | 0.210 |
Why?
|
Thiazolidinediones | 1 | 2006 | 460 | 0.210 |
Why?
|
Membrane Proteins | 4 | 2024 | 7847 | 0.190 |
Why?
|
Nucleic Acid Denaturation | 2 | 2018 | 110 | 0.190 |
Why?
|
Pyrimidines | 3 | 2023 | 3027 | 0.180 |
Why?
|
Proteins | 5 | 2020 | 6030 | 0.180 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11118 | 0.180 |
Why?
|
Receptor, erbB-3 | 1 | 2021 | 143 | 0.180 |
Why?
|
Sensitivity and Specificity | 6 | 2022 | 14649 | 0.180 |
Why?
|
Animals | 38 | 2024 | 168202 | 0.180 |
Why?
|
Camptothecin | 1 | 2023 | 591 | 0.170 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4849 | 0.170 |
Why?
|
Nucleotides, Cyclic | 1 | 2020 | 84 | 0.170 |
Why?
|
Genes, erbB-1 | 1 | 2020 | 162 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 363 | 0.160 |
Why?
|
Interferons | 2 | 2024 | 702 | 0.160 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2018 | 2916 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2024 | 8542 | 0.160 |
Why?
|
Antigens, Neoplasm | 3 | 2024 | 1985 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4570 | 0.160 |
Why?
|
Colorectal Neoplasms | 4 | 2024 | 6927 | 0.160 |
Why?
|
Mouth Neoplasms | 1 | 2024 | 596 | 0.150 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.150 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3868 | 0.150 |
Why?
|
Quality Control | 1 | 2021 | 831 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4021 | 0.150 |
Why?
|
Peptides | 3 | 2008 | 4354 | 0.150 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 239 | 0.150 |
Why?
|
Immunoconjugates | 2 | 2023 | 951 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2018 | 2509 | 0.140 |
Why?
|
Filtration | 1 | 2018 | 228 | 0.140 |
Why?
|
Facial Transplantation | 1 | 2020 | 221 | 0.140 |
Why?
|
Alleles | 3 | 2020 | 6861 | 0.140 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
Cell Culture Techniques | 3 | 2021 | 1662 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 329 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2812 | 0.140 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2447 | 0.140 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2827 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2024 | 982 | 0.140 |
Why?
|
Arm | 1 | 2020 | 588 | 0.140 |
Why?
|
Anilides | 2 | 2016 | 411 | 0.140 |
Why?
|
Poisson Distribution | 1 | 2018 | 504 | 0.130 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 145 | 0.130 |
Why?
|
Salvage Therapy | 2 | 2021 | 1263 | 0.130 |
Why?
|
Thiophenes | 1 | 2020 | 569 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1467 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1056 | 0.130 |
Why?
|
Gene Deletion | 3 | 2020 | 2659 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2896 | 0.120 |
Why?
|
Treatment Outcome | 10 | 2024 | 64572 | 0.120 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2020 | 2057 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4910 | 0.120 |
Why?
|
Immunophenotyping | 2 | 2017 | 1864 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 162 | 0.120 |
Why?
|
Pyrrolidinones | 1 | 2015 | 116 | 0.120 |
Why?
|
Genetic Testing | 2 | 2021 | 3533 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 560 | 0.120 |
Why?
|
Apoptosis | 5 | 2021 | 9476 | 0.120 |
Why?
|
Female | 36 | 2024 | 392203 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 432 | 0.110 |
Why?
|
Sulfonamides | 2 | 2020 | 1977 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1125 | 0.110 |
Why?
|
Quinolines | 2 | 2020 | 764 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 546 | 0.110 |
Why?
|
Genomics | 2 | 2021 | 5822 | 0.110 |
Why?
|
Pyridines | 4 | 2020 | 2875 | 0.110 |
Why?
|
Neovascularization, Pathologic | 2 | 2020 | 2644 | 0.110 |
Why?
|
Piperazines | 3 | 2022 | 2521 | 0.110 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2019 | 617 | 0.110 |
Why?
|
Tumor Burden | 1 | 2019 | 1892 | 0.110 |
Why?
|
Specimen Handling | 1 | 2018 | 701 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.110 |
Why?
|
Quinazolinones | 1 | 2014 | 221 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2722 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1727 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1008 | 0.100 |
Why?
|
Immunity | 1 | 2018 | 994 | 0.100 |
Why?
|
Amino Acid Sequence | 5 | 2011 | 13442 | 0.100 |
Why?
|
Nerve Growth Factors | 1 | 2015 | 564 | 0.100 |
Why?
|
Cell Separation | 1 | 2018 | 1718 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9277 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 487 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1639 | 0.100 |
Why?
|
Cystic Fibrosis | 3 | 2006 | 1285 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 733 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2020 | 5239 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 955 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2018 | 2863 | 0.100 |
Why?
|
Male | 29 | 2024 | 360402 | 0.100 |
Why?
|
Molecular Sequence Data | 5 | 2011 | 17630 | 0.090 |
Why?
|
Substrate Specificity | 3 | 2010 | 1790 | 0.090 |
Why?
|
Middle Aged | 20 | 2024 | 220603 | 0.090 |
Why?
|
Biocatalysis | 1 | 2011 | 170 | 0.090 |
Why?
|
Mitochondria | 2 | 2020 | 3619 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2024 | 3045 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3205 | 0.090 |
Why?
|
Phosphoserine | 1 | 2010 | 203 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2425 | 0.090 |
Why?
|
Disease-Free Survival | 5 | 2021 | 6807 | 0.090 |
Why?
|
Microdissection | 3 | 2005 | 151 | 0.090 |
Why?
|
Area Under Curve | 2 | 2014 | 1635 | 0.080 |
Why?
|
Genetic Loci | 1 | 2019 | 2624 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2010 | 126 | 0.080 |
Why?
|
Pilot Projects | 2 | 2021 | 8619 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2010 | 531 | 0.080 |
Why?
|
Cell Proliferation | 7 | 2020 | 10429 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1852 | 0.080 |
Why?
|
ras Proteins | 2 | 2014 | 1054 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2208 | 0.080 |
Why?
|
Computational Biology | 3 | 2010 | 3509 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3164 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4218 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4408 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2049 | 0.080 |
Why?
|
Protein Stability | 1 | 2010 | 578 | 0.080 |
Why?
|
Phosphorylation | 5 | 2011 | 8311 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2533 | 0.080 |
Why?
|
Basophils | 1 | 2010 | 407 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3550 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 865 | 0.070 |
Why?
|
Enzyme Activation | 2 | 2010 | 3591 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2010 | 2456 | 0.070 |
Why?
|
Prognosis | 5 | 2020 | 29601 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4252 | 0.070 |
Why?
|
Aged | 14 | 2024 | 169092 | 0.070 |
Why?
|
Up-Regulation | 2 | 2020 | 4117 | 0.070 |
Why?
|
Complex Mixtures | 1 | 2006 | 29 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5463 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 1404 | 0.070 |
Why?
|
Graft Rejection | 1 | 2020 | 4438 | 0.070 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2006 | 161 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10072 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5369 | 0.070 |
Why?
|
Breast Neoplasms | 5 | 2017 | 20988 | 0.060 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2010 | 620 | 0.060 |
Why?
|
Gene Expression Profiling | 6 | 2015 | 9417 | 0.060 |
Why?
|
Lasers | 3 | 2005 | 952 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2008 | 304 | 0.060 |
Why?
|
Reproducibility of Results | 7 | 2021 | 20077 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2008 | 481 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10175 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3611 | 0.060 |
Why?
|
Digitoxin | 1 | 2004 | 19 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1336 | 0.060 |
Why?
|
Protein Transport | 1 | 2010 | 1966 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 1 | 2010 | 1113 | 0.060 |
Why?
|
Oligopeptides | 1 | 2010 | 1185 | 0.060 |
Why?
|
Prospective Studies | 5 | 2021 | 54364 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 719 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58919 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1169 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
Epitopes | 1 | 2010 | 2501 | 0.060 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 4 | 2006 | 283 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18220 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3820 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2024 | 214 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 77 | 0.050 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2003 | 81 | 0.050 |
Why?
|
DNA | 2 | 2015 | 7196 | 0.050 |
Why?
|
Peptide Fragments | 2 | 2020 | 5109 | 0.050 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 42 | 0.050 |
Why?
|
Macaca mulatta | 1 | 2010 | 2328 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6126 | 0.050 |
Why?
|
Protein S | 1 | 2002 | 29 | 0.050 |
Why?
|
Electron Transport Complex IV | 1 | 2003 | 190 | 0.050 |
Why?
|
NIH 3T3 Cells | 2 | 2018 | 669 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6483 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 107 | 0.050 |
Why?
|
STAT1 Transcription Factor | 2 | 2018 | 340 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2021 | 424 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 469 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1606 | 0.050 |
Why?
|
Gene Frequency | 2 | 2021 | 3601 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
Infertility, Male | 1 | 2005 | 396 | 0.050 |
Why?
|
Cluster Analysis | 3 | 2015 | 2703 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
Phosphatidylserines | 1 | 2002 | 188 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3310 | 0.050 |
Why?
|
Models, Biological | 3 | 2020 | 9461 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6223 | 0.050 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2017 | 737 | 0.050 |
Why?
|
Lymphatic System | 1 | 2002 | 253 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2004 | 696 | 0.050 |
Why?
|
Peptide Mapping | 3 | 2006 | 262 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 2002 | 320 | 0.050 |
Why?
|
Fertility | 1 | 2005 | 769 | 0.040 |
Why?
|
Transcription Factors | 1 | 2020 | 12116 | 0.040 |
Why?
|
Cell Line | 2 | 2011 | 15577 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 51 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 878 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 285 | 0.040 |
Why?
|
Adult | 13 | 2024 | 220995 | 0.040 |
Why?
|
Antibodies | 2 | 2024 | 2413 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10754 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4512 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 383 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 133 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 99 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2001 | 624 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2005 | 1151 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2222 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
Mice, Nude | 2 | 2018 | 3606 | 0.040 |
Why?
|
Histones | 1 | 2008 | 2577 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2020 | 883 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3705 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2024 | 1355 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 793 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 141 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2020 | 870 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1691 | 0.030 |
Why?
|
Phagocytosis | 1 | 2002 | 1526 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2016 | 63 | 0.030 |
Why?
|
Organ Specificity | 1 | 2001 | 1964 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2261 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1657 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 744 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2010 | 3839 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1336 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 671 | 0.030 |
Why?
|
Prostatic Neoplasms | 3 | 2003 | 11107 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 610 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1756 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11069 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6473 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3268 | 0.030 |
Why?
|
Lung | 3 | 2016 | 9999 | 0.030 |
Why?
|
Dogs | 2 | 2010 | 3837 | 0.030 |
Why?
|
Prostate | 1 | 2003 | 1773 | 0.030 |
Why?
|
Silver Staining | 2 | 2006 | 62 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1230 | 0.030 |
Why?
|
Smad Proteins | 1 | 2015 | 156 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2001 | 3088 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1878 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2625 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 903 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 338 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3145 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2057 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 276 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2006 | 3672 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 302 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2015 | 8603 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2003 | 2821 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2019 | 18937 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 849 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3575 | 0.030 |
Why?
|
Cell-Free System | 1 | 2014 | 339 | 0.030 |
Why?
|
3T3-L1 Cells | 1 | 2013 | 209 | 0.030 |
Why?
|
Algorithms | 3 | 2010 | 14024 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7583 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1118 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1730 | 0.030 |
Why?
|
Breast | 2 | 2017 | 1963 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 965 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1088 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 630 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1483 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 799 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 899 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 359 | 0.020 |
Why?
|
Plasma | 1 | 2014 | 586 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2329 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5780 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4392 | 0.020 |
Why?
|
Cyclin B | 1 | 2009 | 104 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6188 | 0.020 |
Why?
|
Cell Movement | 1 | 2001 | 5201 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2010 | 427 | 0.020 |
Why?
|
Haplorhini | 1 | 2010 | 525 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2043 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1520 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2006 | 9586 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2009 | 213 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 817 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3447 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2010 | 704 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2010 | 717 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 3998 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 265 | 0.020 |
Why?
|
Adipose Tissue, Brown | 1 | 2013 | 762 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 638 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 265 | 0.020 |
Why?
|
Blotting, Western | 2 | 2006 | 5034 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5863 | 0.020 |
Why?
|
Insulin | 2 | 2013 | 6593 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3501 | 0.020 |
Why?
|
Sulfur Radioisotopes | 1 | 2006 | 113 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 699 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15702 | 0.020 |
Why?
|
Adipocytes | 1 | 2013 | 1187 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39062 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2008 | 957 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2009 | 655 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2010 | 1989 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 80583 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 292 | 0.020 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2005 | 49 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2955 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4739 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 982 | 0.020 |
Why?
|
Cardiac Glycosides | 1 | 2004 | 29 | 0.010 |
Why?
|
Serum | 1 | 2006 | 208 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14388 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2008 | 1697 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 871 | 0.010 |
Why?
|
Indicator Dilution Techniques | 1 | 2003 | 43 | 0.010 |
Why?
|
Methionine | 1 | 2006 | 572 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4810 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 211 | 0.010 |
Why?
|
Catalysis | 1 | 2005 | 773 | 0.010 |
Why?
|
HeLa Cells | 1 | 2009 | 3088 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1742 | 0.010 |
Why?
|
Acrylic Resins | 1 | 2003 | 135 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1540 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2005 | 397 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4615 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7373 | 0.010 |
Why?
|
Prostatic Diseases | 1 | 2002 | 57 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1626 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2747 | 0.010 |
Why?
|
Testis | 1 | 2005 | 792 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10708 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2817 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2829 | 0.010 |
Why?
|
Protein Binding | 2 | 2005 | 9345 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15908 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2008 | 938 | 0.010 |
Why?
|
Cell Cycle | 1 | 2009 | 2929 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3419 | 0.010 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 450 | 0.010 |
Why?
|
Spermatozoa | 1 | 2005 | 629 | 0.010 |
Why?
|
Cattle | 1 | 2006 | 3841 | 0.010 |
Why?
|
Body Fluids | 1 | 2002 | 320 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2005 | 2178 | 0.010 |
Why?
|
Nipples | 1 | 2002 | 229 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12719 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22117 | 0.010 |
Why?
|
Rats | 2 | 2006 | 23716 | 0.010 |
Why?
|
Protein Subunits | 1 | 2003 | 942 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1603 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13495 | 0.010 |
Why?
|
Brain | 1 | 2006 | 27100 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2005 | 12759 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6390 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4569 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1242 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2005 | 1118 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41464 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16572 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3410 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11874 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1901 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12420 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 3606 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9171 | 0.010 |
Why?
|
United States | 1 | 2021 | 72292 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2002 | 2465 | 0.010 |
Why?
|
Carcinoma | 1 | 2003 | 2328 | 0.010 |
Why?
|
Time Factors | 2 | 2003 | 39908 | 0.010 |
Why?
|
Biopsy | 1 | 2002 | 6763 | 0.010 |
Why?
|
Macrophages | 1 | 2002 | 5758 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 12966 | 0.000 |
Why?
|
Research Design | 1 | 2002 | 6174 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15250 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 22153 | 0.000 |
Why?
|
Child | 1 | 2006 | 80089 | 0.000 |
Why?
|
Adolescent | 1 | 2006 | 88247 | 0.000 |
Why?
|